Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
作者： Genevieve M. Weir , Robert S. Liwski , Marc Mansour
关键词:
摘要: … for treating cancer in the context of chemotherapy [2]. However, the importance of the immune system and how it interacts with the tumor … can be combined for enhanced tumor rejection. …
mdpi.com
sci-hub.se 参考文章(144)
Eduardo M. Sotomayor, Ivan Borrello, Erev Tubb, Frédérique-Marie Rattis, Harold Bien, Zhengbin Lu, Steve Fein, Stephen Schoenberger, Hyam I. Levitsky, Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nature Medicine. ,vol. 5, pp. 780- 787 ,(1999) , 10.1038/10503
Stephanie K. Bunt, Pratima Sinha, Virginia K. Clements, Jeff Leips, Suzanne Ostrand-Rosenberg, Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression Journal of Immunology. ,vol. 176, pp. 284- 290 ,(2006) , 10.4049/JIMMUNOL.176.1.284
Ajay V. Maker, Peter Attia, Steven A. Rosenberg, Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade Journal of Immunology. ,vol. 175, pp. 7746- 7754 ,(2005) , 10.4049/JIMMUNOL.175.11.7746
Erica M. Hanson, Virginia K. Clements, Pratima Sinha, Dan Ilkovitch, Suzanne Ostrand-Rosenberg, Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells Journal of Immunology. ,vol. 183, pp. 937- 944 ,(2009) , 10.4049/JIMMUNOL.0804253
Bond Almand, Joseph I. Clark, Ekaterina Nikitina, James van Beynen, Nicholas R. English, Stella C. Knight, David P. Carbone, Dmitry I. Gabrilovich, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. Journal of Immunology. ,vol. 166, pp. 678- 689 ,(2001) , 10.4049/JIMMUNOL.166.1.678
S. Audia, A. Nicolas, D. Cathelin, N. Larmonier, C. Ferrand, P. Foucher, A. Fanton, E. Bergoin, M. Maynadie, L. Arnould, A. Bateman, B. Lorcerie, E. Solary, B. Chauffert, B. Bonnotte, Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clinical and Experimental Immunology. ,vol. 150, pp. 523- 530 ,(2007) , 10.1111/J.1365-2249.2007.03521.X
Giorgio Zauli, Rita Rezzani, Soldano Ferrone, Moris Cadei, Luigi Rodella, Daniel J. Hicklin, Piergiovanni Grigolato, Marco Vitale, HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Research. ,vol. 58, pp. 737- 742 ,(1998)
Mohamed L Salem, C Marcela Díaz-Montero, Amir A Al-Khami, Sabry A El-Naggar, Osama Naga, Alberto J Montero, Ahmed Khafagy, David J Cole, None, Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C) Journal of Immunology. ,vol. 182, pp. 2030- 2040 ,(2009) , 10.4049/JIMMUNOL.0801829
Srinivas Nagaraj, Adam G. Schrum, Hyun-Il Cho, Esteban Celis, Dmitry I. Gabrilovich, Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells Journal of Immunology. ,vol. 184, pp. 3106- 3116 ,(2010) , 10.4049/JIMMUNOL.0902661
Judah Folkman, Birgit M. Kräling, Catherine E. Butterfield, Blair Marshall, Timothy Browder, Michael S. O’Reilly, Bin Shi, Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer Cancer Research. ,vol. 60, pp. 1878- 1886 ,(2000)